36 studies found for:    " September 28, 2011":" October 28, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 28, 2011":" October 28, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
2 Unknown  A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
3 Active, not recruiting A Commitment Device for Medication Adherence Among HIV Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Intervention: Other: Medication Adherence among HIV/AIDS Patients
4 Recruiting Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
5 Completed Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Darunavir/Ritonavir (DRV/r);   Drug: Lopinavir in fixed combination with Ritonavir;   Drug: Zidovudine;   Drug: NRTIs;   Drug: Efavirenz
6 Unknown  Dimiracetam in Painful Neuropathies Affecting AIDS Patients
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: Dimiracetam;   Drug: Dimiracetam 25 mg
7 Completed Problems With Immune Recovery in the Gut Tissue
Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
8 Active, not recruiting Tissue Drug Levels of HIV Medications
Condition: Human Immunodeficiency Virus
Intervention: Drug: Initiation of anti-retroviral therapy
9 Active, not recruiting
Has Results
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg OAD;   Drug: darunavir 800mg OAD;   Drug: ritonavir 100mg OAD
10 Active, not recruiting Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
Condition: Human Immunodeficiency Virus
Intervention:
11 Completed Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV
Condition: HIV Infection
Intervention:
12 Unknown  Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos
Conditions: HIV;   AIDS
Intervention: Behavioral: Video or In-Person Presentation
13 Completed Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho
Conditions: HIV/AIDS;   Tuberculosis;   Diabetes Mellitus;   Arterial Hypertension
Interventions: Other: Door-to-door;   Other: Pitso
14 Completed
Has Results
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Condition: Hepatitis C Virus Genotype-1
Interventions: Drug: TMC435;   Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin
15 Completed A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)
Condition: HIV
Interventions: Drug: Lopinavir ritonavir;   Drug: Atazanavir ritonavir;   Drug: Efavirenz
16 Recruiting RAltegravir Switch STudy: Effects on Endothelial Recovery
Conditions: HIV Infection;   Endothelial Dysfunction
Intervention: Drug: raltegravir
17 Active, not recruiting Renal Transplantation and Raltegravir in HIV-Infected Patients
Conditions: HIV-1 Infection;   Chronic Renal Insufficiency
Intervention: Drug: Raltegravir
18 Enrolling by invitation Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
Conditions: HIV;   Brain Tumors;   Neurofibromatosis 1
Intervention:
19 Completed Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors
Conditions: HIV;   Dyslipidemia
Interventions: Drug: Truvada® (300 mg tenofovir disoproxil fumarato/200 mg emtricitabine);   Drug: Placebo
20 Active, not recruiting Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
Condition: HIV
Intervention: Behavioral: Peer Navigator Intervention

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years